Chronic Liver Inflammation in Dogs (Chronic Hepatitis)
- Occurrence: common
- Location of disease: Abdomen/pelvis
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Chronic hepatitis in dogs is a long-lasting inflammation of the liver that leads to progressive damage of liver tissue and can impair normal liver function.
The most important facts at a glance
Chronic hepatitis in dogs is a persistent inflammation of the liver that can impair its vital functions. This inflammation can be caused by infections, genetic factors, autoimmune diseases, or environmental factors. An autoimmune response, where the immune system attacks liver cells, is a common cause and occurs particularly in certain breeds. Infections and toxic substances can also be triggers. Symptoms include loss of appetite, Vomiting, increased thirst, jaundice, and weakness. Diagnosis is made based on clinical symptoms, blood tests, and imaging procedures. A liver biopsy may be required for confirmation. Therapy aims to reduce inflammation and relieve the liver. Immunosuppressive medications or antimicrobial therapies can be used, supplemented by special diets and nutritional supplements. Regular veterinary check-ups are important to monitor the course of the disease. The prognosis depends on the severity and cause of the disease, as well as the response to therapy. Prevention focuses on minimizing risk factors and early detection of symptoms. Research aims to better understand genetic predispositions and environmental factors to develop more effective prevention and therapy strategies.
Causes
The liver is a vital organ that performs numerous functions, including the production of proteins, the storage of vitamins and minerals, and the detoxification of blood. Liver inflammation, as seen in chronic hepatitis, can significantly impair these functions.
Chronic hepatitis involves persistent inflammation of the liver tissue. This inflammation can be triggered by a variety of causes, including infections, genetic factors, autoimmune diseases, or environmental factors. The inflammation leads to the destruction of liver cells and can, over time, result in cirrhosis (Scar tissue formation) and ultimately cirrhosis, where liver function is severely restricted.
One of the most common causes of chronic hepatitis in dogs is an autoimmune response, where the immune system mistakenly recognizes and attacks liver cells as foreign. These autoimmune diseases can be genetically determined and are more common in certain breeds, including Dobermans, Cocker Spaniels, and West Highland White Terriers.
Infections caused by certain viruses, such as canine adenovirus, or bacteria can also lead to chronic inflammation of the liver. Similarly, toxic substances ingested by dogs, such as certain medications or environmental toxins, can damage the liver and trigger chronic hepatitis.
Symptoms
The symptoms of chronic hepatitis in dogs can be subtle and nonspecific in the early stages of the disease. Often, owners only notice symptoms when the disease has already progressed.
Common symptoms include loss of appetite, Weight loss, and lethargy. These general signs can be easily overlooked or attributed to other health problems. Further symptoms include Vomiting and Diarrhea, which can be caused by impaired liver function.
Jaundice, recognizable by a yellowish discoloration of the skin and mucous membranes, occurs when the liver is no longer able to effectively process bilirubin, a breakdown product of red blood pigment. In severe cases, ascites can occur, an accumulation of fluid in the abdominal cavity, leading to a bloated abdomen.
Therapy
The therapy for chronic hepatitis in dogs aims to reduce inflammation, alleviate symptoms, and prevent further liver damage. The specific therapy depends on the underlying cause of the hepatitis.
For autoimmune-related hepatitis, immunosuppressive medications such as corticosteroids can be used to suppress the immune response and reduce inflammation. If an infection is the cause, appropriate antimicrobial therapy may be required.
In addition to drug treatment, a special diet may be needed to relieve the liver. These diets are often low in protein and high in antioxidants to support the liver. Supplements such as S-adenosylmethionine (SAMe) or milk thistle can also help support liver health.
Regular veterinary check-ups are important to monitor the course of the disease and adjust therapy accordingly. In severe cases, hospitalized care may be necessary, especially if complications such as ascites or liver failure occur.
Prognosis and follow-up care
The prognosis for dogs with chronic hepatitis varies greatly and depends on several factors, including the severity of the disease at the time of diagnosis, the underlying cause, and the response to therapy.
Cases diagnosed and treated early can have a good prognosis, especially if the inflammation was caused by a treatable cause such as an infection or a reversible toxic exposure. Dogs that respond well to therapy and whose condition is well-monitored can enjoy a good quality of life.
In advanced cases, where significant liver damage or cirrhosis is already present, the prognosis is less favorable. These dogs may require more intensive therapy and close monitoring to avoid complications.
Prevention
The prevention of chronic hepatitis in dogs focuses on minimizing risk factors and early detection of symptoms. A balanced diet and avoidance of toxins are crucial measures.
Regular veterinary check-ups are important to detect and address signs of liver problems early. Owners should be careful not to give their dogs medications that have not been specifically prescribed by a veterinarian, as some of them can be hepatotoxic.
For dogs that are genetically predisposed, regular monitoring of liver function can be helpful to react to changes early. For some infectious causes, such as canine adenovirus, vaccinations are available that can reduce the risk of liver inflammation.
Outlook on current research
Research into chronic hepatitis in dogs is a dynamic and constantly evolving field. A central goal of current studies is to better understand the genetic predispositions and environmental factors that contribute to the development of this disease. By identifying specific genetic markers, scientists hope to develop breeding programs that can reduce the risk of the disease in affected breeds.
Another key research area is the improvement of diagnostic procedures. Currently, many diagnoses are based on invasive procedures such as liver biopsies. Researchers are working to develop non-invasive methods that enable earlier and more accurate diagnosis. Imaging procedures and blood tests that can detect specific biomarkers for liver inflammation are promising approaches in this area.
At the therapeutic level, research is investigating new drug therapy options that specifically target the inflammatory processes in the liver. The role of anti-inflammatory drugs and immunomodulators is being intensively researched to improve the quality of life and survival rate of affected dogs. In parallel, there are studies that focus on the role of nutrition in supporting liver health to promote the liver’s regenerative capacity.
There is also growing interest in the role of microorganisms in the gut (microbiome) and their influence on liver health. Researchers are investigating how a disturbed intestinal flora / gut microbiota can contribute to the development or worsening of chronic hepatitis and whether probiotics or prebiotics can be used as supportive therapies.
In summary, research into chronic hepatitis in dogs aims to gain deeper insights into the causes and mechanisms of the disease to develop more effective prevention and therapy strategies. The hope is that these findings will not only improve the quality of life of affected animals but also expand therapy options for other inflammatory liver diseases in pets.
Frequently Asked Questions (FAQs)
1. What is Chronic Hepatitis in Dogs?
2. Symptoms: What symptoms does a dog with Chronic Hepatitis show?
3. How is Chronic Hepatitis in Dogs diagnosed?
4. Which dog breeds are most commonly affected?
5. Can Chronic Hepatitis in Dogs be cured?
6. What treatment options are available for affected dogs?
7. How can I improve my dog's quality of life with Chronic Hepatitis?
8. Is Chronic Hepatitis in Dogs contagious?
9. Are there preventive measures for Chronic Hepatitis?
10. Will Chronic Hepatitis shorten my dog's lifespan?
Literature
- Webster, C. R. L., Center, S. A., Cullen, J. M., Penninck, D. G., Richter, K. P., Twedt, D. C., & Watson, P. J. (2019). ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. Journal of Veterinary Internal Medicine, 33(3), 1173–1200. https://doi.org/10.1111/jvim.15467
- Ullal, T., Center, S. A., & Dirksen, K. (2025). Comparative review of copper-associated chronic hepatitis in dogs and Wilson disease in humans. Frontiers in Veterinary Science, 12, Article 1692603. https://doi.org/10.3389/fvets.2025.1692603
- Rothuizen, J., Bunch, S. E., Charles, J. A., Cullen, J. M., Desmet, V. J., Szatmári, V., Twedt, D. C., van den Ingh, T. S. G. A. M., Van Winkle, T., & Washabau, R. J. (2006). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases. Elsevier. https://doi.org/10.1016/B978-0-7020-2791-8.X5001-1
- den Boer, E. R., Dirksen, K., Center, S. A., & Fieten, H. (2025). Copper-associated chronic hepatitis in dogs. Veterinary Clinics of North America: Small Animal Practice. Advance online publication.
- Mutton, J., Bloxham, A. K., Gieseg, M. A., & Langova, V. (2024). Copper hepatopathies in Australian dogs. Journal of Veterinary Internal Medicine, 38(3), 1743–1752. https://doi.org/10.1111/jvim.17082
- Rodrigues, A., Leal, R. O., Girod, M., Dally, C., Guery, E., Gomes, E., & Hernandez, J. (2020). Canine copper-associated hepatitis: A retrospective study of 17 clinical cases. Open Veterinary Journal, 10(2), 128–134. https://doi.org/10.4314/ovj.v10i2.2
- Gori, E., Pierini, A., Meucci, V., Abramo, F., Muscatello, L. V., & Marchetti, V. (2021). Hepatic lead and copper concentrations in dogs with chronic hepatitis and their relationship with hematology, serum biochemistry, and histopathology. Journal of Veterinary Internal Medicine, 35(4), 1773–1779. https://doi.org/10.1111/jvim.16149
- Poldervaart, J. H., Favier, R. P., Penning, L. C., van den Ingh, T. S. G. A. M., & Rothuizen, J. (2009). Primary hepatitis in dogs: A retrospective review (2002–2006). Journal of Veterinary Internal Medicine, 23(1), 72–80. https://doi.org/10.1111/j.1939-1676.2008.0215.x
- Webster, C. R. L., Center, S. A., Cullen, J. M., Penninck, D. G., Richter, K. P., Twedt, D. C., & Watson, P. J. (2019). ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. Journal of Veterinary Internal Medicine, 33(3), 1173–1200. https://doi.org/10.1111/jvim.15467
- Ullal, T., Center, S. A., & Dirksen, K. (2025). Comparative review of copper-associated chronic hepatitis in dogs and Wilson disease in humans. Frontiers in Veterinary Science, 12, Article 1692603. https://doi.org/10.3389/fvets.2025.1692603
- Rothuizen, J., Bunch, S. E., Charles, J. A., Cullen, J. M., Desmet, V. J., Szatmári, V., Twedt, D. C., van den Ingh, T. S. G. A. M., Van Winkle, T., & Washabau, R. J. (2006). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases. Elsevier. https://doi.org/10.1016/B978-0-7020-2791-8.X5001-1
- den Boer, E. R., Dirksen, K., Center, S. A., & Fieten, H. (2025). Copper-associated chronic hepatitis in dogs. Veterinary Clinics of North America: Small Animal Practice. Advance online publication.
- Mutton, J., Bloxham, A. K., Gieseg, M. A., & Langova, V. (2024). Copper hepatopathies in Australian dogs. Journal of Veterinary Internal Medicine, 38(3), 1743–1752. https://doi.org/10.1111/jvim.17082
- Rodrigues, A., Leal, R. O., Girod, M., Dally, C., Guery, E., Gomes, E., & Hernandez, J. (2020). Canine copper-associated hepatitis: A retrospective study of 17 clinical cases. Open Veterinary Journal, 10(2), 128–134. https://doi.org/10.4314/ovj.v10i2.2
- Gori, E., Pierini, A., Meucci, V., Abramo, F., Muscatello, L. V., & Marchetti, V. (2021). Hepatic lead and copper concentrations in dogs with chronic hepatitis and their relationship with hematology, serum biochemistry, and histopathology. Journal of Veterinary Internal Medicine, 35(4), 1773–1779. https://doi.org/10.1111/jvim.16149
- Poldervaart, J. H., Favier, R. P., Penning, L. C., van den Ingh, T. S. G. A. M., & Rothuizen, J. (2009). Primary hepatitis in dogs: A retrospective review (2002–2006). Journal of Veterinary Internal Medicine, 23(1), 72–80. https://doi.org/10.1111/j.1939-1676.2008.0215.x